Latest Regulatory Development News

Page 4 of 18
Generation Development Group (ASX, GDG) has reported a robust December quarter, with Funds Under Management surging across its core divisions, driven by strategic partnerships and acquisitions.
Claire Turing
Claire Turing
22 Jan 2026
Hazer Group advances its methane pyrolysis technology commercialization with a landmark alliance deal, extended partnerships, and a strengthened cash position, positioning itself at the forefront of low-carbon hydrogen and steelmaking solutions.
Maxwell Dee
Maxwell Dee
22 Jan 2026
Coast Entertainment reports a robust first half of FY26 with significant growth in ticket sales and visitation, driven by new attractions and strong promotional campaigns. The Group also strengthens its financial position amid ongoing economic challenges.
Victor Sage
Victor Sage
21 Jan 2026
The Calmer Co. International Limited has reported its highest ever monthly sales of $910,767 in December 2025, driven by strong wholesale growth and expanding US market presence.
Victor Sage
Victor Sage
14 Jan 2026
Osmond Resources is fast-tracking development of its Orión EU Critical Minerals Project, with initial drilling confirming high-grade titanium, zircon, and rare earth elements. The company aims to complete a maiden Mineral Resource Estimate and Scoping Study by mid-2026.
Maxwell Dee
Maxwell Dee
13 Jan 2026
Saluda Medical has received CE certification for its EVA™ Sensing Technology, enabling commercialisation in Europe and recognition in Australia following prior FDA approval. This milestone sets the stage for a broader rollout of its personalised spinal cord stimulation therapy in early 2026.
Ada Torres
Ada Torres
22 Dec 2025
Seven West Media shareholders have overwhelmingly approved the proposed acquisition by Southern Cross Media Group, clearing a major hurdle ahead of final court approval.
Elise Vega
Elise Vega
22 Dec 2025
Seven West Media shareholders have overwhelmingly approved the proposed acquisition by Southern Cross Media Group, clearing a major hurdle ahead of final court approval.
Elise Vega
Elise Vega
22 Dec 2025
Mayne Pharma reports mixed early FY26 results with strong prescription growth in Women’s Health and improved Dermatology margins, while strategic reviews and litigation loom.
Ada Torres
Ada Torres
22 Dec 2025
African Gold secures ASX waiver allowing cancellation of options without shareholder approval as part of Montage Gold acquisition scheme. This regulatory step smooths the path for the proposed takeover and option restructuring.
Maxwell Dee
Maxwell Dee
19 Dec 2025
Robex Resources has amended its acquisition agreement with Predictive Discovery, lowering the exchange ratio and postponing the shareholder meeting to December 30, 2025. The Robex Board unanimously recommends approval, supported by updated fairness opinions.
Maxwell Dee
Maxwell Dee
19 Dec 2025
TT Investments, led by Tony Pitt, has initiated an unconditional on-market takeover offer for 360 Capital Group at $0.31 per security, representing a 24% premium to recent trading prices. The bidder already controls over 96% of the group’s securities.
Victor Sage
Victor Sage
19 Dec 2025